Stemline Therapeutics Stock Price (NASDAQ:STML)

Add to My Stocks
$8.45 $0.05 (0.59%) STML stock closing price Mar 24, 2017 (Closing)
Stemline Therapeutics
24 MAR 2017
amigobulls logo
STML hand_up
STML vs S&P 500
Closing Price: Mar 24, 2017
$8.45 ( -0.59%)
S&P 500
2344 ( -0.08%)
52 Week Price Range
1 Year Return: 87.22%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Stemline Therapeutics Snapshot Video

12 5 2

STML Stock Details

Prev Close* : $8.50
Market Cap:
Day Low: $8.4
52 Week Low: $4.06
Open: $8.5
Volume: 135934
Day High: $8.7
52 Week High: $14.60

Latest Stock Market News

Latest Articles

Stemline Therapeutics News - From Partners

STML Stockcharts

View STML PE ratio, PS ratio stocks charts and compare with peers.
STML Chart
Note: Compare Stemline Therapeutics stock price history with the index and industry peers.

Stemline Therapeutics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Stemline Therapeutics Financial Ratios

Asset Turnover

STML Industry Peers

Company Price Change (%)
Nicox (NICXF)9.450 (0%)
Protagonist Thr (PTGX)13.220.07 (0.53%)
Karyopharm Therapeutics (KPTI)10.480.12 (1.16%)
Celgene (CELG)123.380.16 (0.13%)
Agenus (AGEN)3.880.04 (1.02%)
Immunocellular Therapeutics (IMUC)2.690 (0%)
Seattle Genetics (SGEN)63.690.47 (0.74%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Enzo Biochem (ENZ)8.430.52 (6.57%)
Peregrine Pharma (PPHM)0.7060.03 (4.44%)
Ophthotech (OPHT)3.530.15 (4.44%)
Kindred Biosciences (KIN)7.20.3 (4.35%)
Fortress Biotech (FBIO)3.60.14 (4.05%)
Immunomedics (IMMU)6.880.25 (3.77%)
Compugen (CGEN)4.350.15 (3.57%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)1.750.18 (9.35%)
Vital Therapies (VTL)3.850.15 (3.75%)
MannKind (MNKD)1.890.06 (3.08%)
PDL BioPharma (PDLI)1.980.05 (2.46%)
Sangamo BioSciences (SGMO)4.10.1 (2.38%)
Sorrento Therapeutics (SRNE)4.10.1 (2.38%)
Ultragenyx Pharma (RARE)70.321.67 (2.32%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017

Stemline Therapeutics Inc Stock News - Partner Headlines

Stemline Therapeutics Financial Statements

income statement20152014201320122011
Net Sales Or Revenues0.65M0.33M0.07M--
Net Income-37.24M-28.82M-24.19M-6.27M-2.75M
Total Operating Expense38.27M29.32M24.04M6.46M2.7M
view Stemline Therapeutics Inc income statement
balance sheet20152014201320122011
Total Assets98.21M60.49M85.28M5.02M6.45M
Total Liabilities10.1M5.08M5.65M7.53M3.24M
Shareholders Equity88.11M55.41M79.62M-2.5M3.2M
view Stemline Therapeutics Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities6M-1.71M2.66M1.53M0.6M
Net Cash From (Used By) Operating Activities-25.58M-25.71M-16.11M-4.12M-1.93M
Increase (Decrease) In Prop Plant And Equipment-0.01M--0.46M--
view Stemline Therapeutics Inc cashflow statement

Stemline Therapeutics Stock Message Board

Stemline Therapeutics stock price ended the last trading day at 8.45. Stemline Therapeutics market capitalization is 212.96M and it represents the total market value of STML stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Stemline Therapeutics stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Stemline Therapeutics is worth a lot, it will most likely be reflected in an inflated Stemline Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 135934 STML shares were traded yesterday, and Stemline Therapeutics stock chart shows that the STML stock quote hit a day high of 8.7 and day low of 8.4. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of STML, view Stemline Therapeutics stock price history.